ZO Multi-Therapy Hydroquinone System
Natural health product licensed in Canada
- Licence holder
- ZO Skin Health Inc.
- NPN or DIN-HM
- 80064165
- Status
- Inactive licence
- Licence date
- 22 September 2015
- Revision date
- Not provided
- Form
- Crème
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 1,4-Benzènediol | 4 % |
| Dioxyde de titane | 8 % |
Non-medicinal ingredients
Squalène, Phytosphingosine, EDTA de sodium, Aqua, Stéarate de PEG-100, Chlorure de stéapyrium, Stéarate de propylène glycol, Diméthicone, Extrait de branche/fruit/feuille de Nephelium Lappaceum, Poly(acrylamide), Ethylhexylglycérine, Cyclopentasiloxane, Dihydroxycétyle phosphate de sodium, Laureth-7, Néopentanoate d'isodécyle, Extrait de graine de Glycine Soja (Fève soja), Extrait de germes de Brassica oleracea italica (Brocoli), Squalane, Benzoate de sodium, Phényl triméthicone, Carbonate de sodium, Métabisulfite de sodium, Hydroxyde de sodium, Sébacate de di-isopropyle, Extrait de fleurs de Chamomille Recutita (Matricaria), Lauryl lactate, Phénoxyéthanol, Allantoïne, Isoparaffine en C13 à 14, Sulfate de sodium, Butylène glycol, Acide glycolique, Copolymères d'acrylates/de styrènes, Maltodextrine, Chlorphénésine, Sulfite de sodium, Chlorure de sodium, d-alpha tocophérol, Lauryl sulfate de sodium, Dihydrogénophosphate d'aminopropyl, Acide ascorbique, Palmitate d'éthylhexyle, Poly(glycéryl-3) poly(diméthylsiloxyéthyl) diméthicone, Jus de feuilles d'Aloe Barbadensis, bêta-D-glucane, Pentylène glycol, Silice, Caprylyl glycol, Glycérides de palme hydrogénés, Palmitate d'ascorbyle, Homarine HCl, Eau, Extrait de fleur/feuille/tige de Stachys officinalis, Triglycéride caprylique/caprique, Saponines, Alcool stéarylique, Huile de graine de Carthamus Tinctorius (Carthame), Acétate de dl-alpha tocophéryle, Acide stéarique, Propylène glycol, Cétéareth-20, Sorbate de potassium, bêta-glucane, Glycérine, Erythritol, Palmitate de rétinyle, Huile de graines d'Helianthus Annus (tournesol), Mélanine, Hydroxyde d'aluminium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Melamin/Melamix: For the gradual lightening of hyperpigmented skin associated with various skin conditions such as chloasma, melasma, freckles, senile lentigines, and other skin discolourations. Skin bleaching/lightener. Glycogent: Helps to reduce the signs of chronic photodamage. Helps to correct skin discolouration. Provides antioxidants. Oclipse C Broad Spectrum Sunscreen SPF 50: Helps prevent sunburn. Broad Spectrum Sunscreen SPF 50: If used as directed with other sun protection measures, decreases the risk of skin cancer and early skin aging caused by the sun. Filters/screens UVA/UVB rays. Absorbs throughout the UVA/UVB spectrum to provide sunburn protection.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80064165
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.